816 filings
424B3
SNGX
Soligenix Inc
10 May 24
Prospectus supplement
4:16pm
10-Q
2024 Q1
SNGX
Soligenix Inc
Quarterly report
10 May 24
4:05pm
ARS
2023 FY
SNGX
Soligenix Inc
29 Apr 24
Annual report to shareholders
4:03pm
DEF 14A
SNGX
Soligenix Inc
Definitive proxy
29 Apr 24
4:01pm
8-K
SNGX
Soligenix Inc
22 Apr 24
Soligenix Announces Pricing of $4.75 Million Public Offering
4:05pm
424B4
7pg2z
19 Apr 24
Prospectus supplement with pricing info
4:05pm
EFFECT
xuz77owf
17 Apr 24
Notice of effectiveness
12:15am
8-K
xrm0j1m4k2mprawfawwe
3 Apr 24
Randomized Study with 18 Weeks Continuous Treatment Expected to Replicate and Extend Results from the First, Statistically Significant Phase 3 Study
4:05pm
8-K
a7h85gtn6 94j5
22 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
EFFECT
oqsilfsp 8il7
18 Dec 23
Notice of effectiveness
12:15am
8-K
pcg4y0w5k0tkqy0sj
15 Dec 23
Submission of Matters to a Vote of Security Holders
4:03pm
CORRESP
2bxtih4tn
14 Dec 23
Correspondence with SEC
12:00am
CORRESP
f0pvqn
6 Dec 23
Correspondence with SEC
12:00am
CORRESP
8be4v5ym 4y
30 Nov 23
Correspondence with SEC
12:00am